eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase III double blind, placebo controlled study of donepezil in the irradiated brain

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
  4. Additional Topic(s)
    Side effects of radiation therapy
  5. Resource Description
    This randomized phase III trial is studying donepezil to see how well it works in lessening side effects of radiation therapy compared with a placebo in patients who have undergone radiation therapy for brain tumors.
  6. Contact
    Berenberg, Jeffrey
  7. PI
    Berenberg, Jeffrey
  8. Topic
    brain cancer
  9. Study Population
    Participants are 18 years old with diagnosis of primary brain tumor or metastatic brain tumor, at least 6 months since finishing radiation therapy to the brain, and more than 2 weeks since donepezil, methylphenidate, or EGb761.
  10. Funded by
    Cancer Trials Support Unit
  11. Phase
    Phase 3 clinical trial
  12. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016